Variant report

Variant	nsv598346
Chromosome Location	chr5:61575657-61577837
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr5:61560442..61563605-chr5:61575064..61578930,3	K562	blood:
2	chr5:61553876..61556282-chr5:61576708..61578826,2	K562	blood:
3	chr5:61570576..61576152-chr5:61577980..61582631,7	K562	blood:
4	chr5:61574738..61576264-chr5:61698125..61699775,2	K562	blood:
5	chr5:61573722..61577065-chr5:61577950..61581609,5	K562	blood:
6	chr5:61574146..61576082-chr5:61601811..61603666,2	MCF-7	breast:
7	chr5:61576810..61579039-chr5:61601363..61604107,2	K562	blood:

Variant related genes	Relation type
ENSG00000068796	chromatin interactions
ENSG00000086189	chromatin interactions

Extended variants
information (count: 76 )
Associated
traits (count: 91 )

Variant overlapped rSNPs/rCNVs (count:76 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs540827358	chr5:61575657-61575658	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs185708256	chr5:61575667-61575668	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs574556556	chr5:61575717-61575718	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs544268031	chr5:61575755-61575756	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs189316876	chr5:61575776-61575777	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs532182054	chr5:61575800-61575801	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs192326269	chr5:61575832-61575833	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs559747225	chr5:61575844-61575845	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs137917134	chr5:61575875-61575876	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs200777074	chr5:61575878-61575879	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs528793443	chr5:61575912-61575913	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs548462142	chr5:61575915-61575916	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs149553148	chr5:61575944-61575945	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs537128881	chr5:61575948-61575949	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs184523198	chr5:61576002-61576003	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs570503014	chr5:61576030-61576031	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs188789719	chr5:61576048-61576049	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs147015232	chr5:61576049-61576050	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs572211497	chr5:61576075-61576076	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs181243929	chr5:61576102-61576103	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs554782392	chr5:61576149-61576150	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs574716591	chr5:61576160-61576161	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs543532021	chr5:61576183-61576184	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs186234930	chr5:61576187-61576188	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs189464252	chr5:61576199-61576200	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs539690298	chr5:61576224-61576225	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs138220305	chr5:61576242-61576243	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs559317598	chr5:61576288-61576289	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs79931146	chr5:61576425-61576426	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs548893858	chr5:61576475-61576476	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs143715675	chr5:61576489-61576490	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs369001862	chr5:61576535-61576536	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs531051341	chr5:61576540-61576541	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs180715454	chr5:61576574-61576575	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs527503295	chr5:61576579-61576580	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs570565765	chr5:61576580-61576581	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs533482309	chr5:61576583-61576584	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs186425072	chr5:61576591-61576592	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs190867708	chr5:61576614-61576615	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs371071474	chr5:61576617-61576618	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs373549370	chr5:61576633-61576634	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs147203139	chr5:61576641-61576642	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs568255541	chr5:61576652-61576653	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs537194070	chr5:61576662-61576663	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs371977815	chr5:61576707-61576708	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs397703166	chr5:61576725-61576726	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs557200086	chr5:61576733-61576734	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs148663337	chr5:61576753-61576754	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs376207442	chr5:61576755-61576756	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs550365959	chr5:61576775-61576776	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:91)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Multiple myeloma	17550852	CNVD
Thoracic aortic aneurysm	21092924	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Non-small cell lung cancer	21829676	CNVD
Breast cancer	22032731	CNVD
Prostate cancer	21965145	CNVD
Esophageal cancer	20955586	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute myeloid leukemia	21251322	CNVD
Oral cancer	21386901	CNVD
Bladder cancer	21909424	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17133270	CNVD
Breast cancer	19602461	CNVD
Renal cell carcinoma	18194544	CNVD
abnormal development	18461090	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	21364760	CNVD
Colorectal cancer	16774939	CNVD
Myelofibrosis	22110671	CNVD
Neuroticism	17667963	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:34 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:61571600-61577400	Weak transcription	Fetal Intestine Small	intestine
2	chr5:61573200-61576400	Weak transcription	Fetal Intestine Large	intestine
3	chr5:61573600-61575800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr5:61573600-61575800	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
5	chr5:61573600-61576000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
6	chr5:61573800-61575800	Weak transcription	HMEC	breast
7	chr5:61573800-61577800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
8	chr5:61574800-61577400	Weak transcription	K562	blood
9	chr5:61575000-61576800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr5:61575000-61577000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr5:61575000-61577800	Weak transcription	Primary hematopoietic stem cells	blood
12	chr5:61575600-61578000	Enhancers	NHEK	skin
13	chr5:61575800-61576000	Enhancers	GM12878-XiMat	blood
14	chr5:61575800-61576200	Enhancers	Breast Myoepithelial Primary Cells	Breast
15	chr5:61575800-61576400	Enhancers	HepG2	liver
16	chr5:61575800-61578200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
17	chr5:61575800-61579000	Enhancers	HMEC	breast
18	chr5:61575800-61580000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
19	chr5:61576000-61577600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
20	chr5:61576400-61576600	Enhancers	Fetal Intestine Large	intestine
21	chr5:61576400-61576600	Enhancers	Placenta	Placenta
22	chr5:61576600-61577000	Weak transcription	Fetal Intestine Large	intestine
23	chr5:61576800-61577800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
24	chr5:61576800-61579200	Weak transcription	Placenta	Placenta
25	chr5:61577000-61577800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
26	chr5:61577000-61580400	Enhancers	Fetal Intestine Large	intestine
27	chr5:61577400-61578800	Enhancers	Brain Germinal Matrix	brain
28	chr5:61577400-61579600	Enhancers	K562	blood
29	chr5:61577400-61580600	Enhancers	Fetal Intestine Small	intestine
30	chr5:61577800-61578200	Enhancers	Primary hematopoietic stem cells	blood
31	chr5:61577800-61578200	Enhancers	Primary hematopoietic stem cells short term culture	blood
32	chr5:61577800-61578200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
33	chr5:61577800-61578200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
34	chr5:61577800-61579400	Enhancers	Rectal Mucosa Donor 31	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links